
The first-generation zzso growth factor zzso zzso zzso zzso zzso and zzso have been incorporated into treatment zzso for patients with advanced zzso cell lung zzso These agents are particularly effective in a subset of patients whose tumors harbor zzso zzso growth factor zzso zzso However, most patients do not respond to these zzso zzso zzso and those who do will eventually acquire resistance that typically results from a secondary zzso growth factor zzso zzso zzso zzso zzso transition factor amplification, or zzso of other signaling zzso For patients whose tumors have zzso zzso growth factor zzso there are several known mechanisms of initial resistance zzso Kirsten rat zzso viral zzso zzso zzso but these do not account for all cases, suggesting that unknown mechanisms also zzso To potentially overcome the issue of resistance, next-generation zzso zzso zzso are being developed, which zzso block multiple zzso growth factor zzso family members zzso zzso zzso zzso and zzso and/or vascular zzso growth factor zzso pathways zzso zzso and zzso In addition, drugs that block parallel signaling pathways or signaling molecules downstream of the zzso growth factor zzso such as the zzso growth zzso zzso and the zzso target of zzso are undergoing clinical zzso As drug resistance appears to be zzso combinations of drugs or drugs with multiple targets may be more effective in zzso zzso 

